Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome
We reported two patients with refractory eosinophilic fasciitis (EF) and provided a systematic review of the literature to determine the clinical variables associated with prognosis of EF. We enrolled 88 cases, whose clinical characteristics were analyzed by separating the patients into two or three...
Gespeichert in:
| Veröffentlicht in: | Clinical rheumatology 2007-09, Vol.26 (9), p.1445-1451 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1451 |
|---|---|
| container_issue | 9 |
| container_start_page | 1445 |
| container_title | Clinical rheumatology |
| container_volume | 26 |
| creator | Endo, Yukie Tamura, Atsushi Matsushima, Youichiro Iwasaki, Tomoko Hasegawa, Michiko Nagai, Yayoi Ishikawa, Osamu |
| description | We reported two patients with refractory eosinophilic fasciitis (EF) and provided a systematic review of the literature to determine the clinical variables associated with prognosis of EF. We enrolled 88 cases, whose clinical characteristics were analyzed by separating the patients into two or three groups based on outcome. The incidence of certain clinical and pathological features differed among the groups. In particular, the incidence of morphea-like skin lesions in patients with refractory fibrosis was significantly higher than in patients without refractory fibrosis (p = 0.003). Patients with morphea-like skin lesions were 1.9 times more likely to develop persistent fibrosis than patients without these lesions (95% confidence intervals, 1.5-2.5). A younger age (under 12 years) at onset was associated with a 1.6 times greater risk of residual fibrosis (95% confidence interval, 1.1-2.2). Trunk involvement was associated with a 1.4 times greater risk of residual fibrosis (95% confidence interval, 1.0-2.0). Histopathologically, the presence of dermal fibrosclerosis was associated with a 1.4 times greater risk of refractory fibrosis (95% confidence interval, 1.0-2.1). We consider these clinical characteristics, notably the presence of morphea-like skin lesions may be an important risk factor for developing residual fibrosis in EF patients. |
| doi_str_mv | 10.1007/s10067-006-0525-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70770368</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70770368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-2289cb38e107d0998fc03a4951bd2c7c09fa94e57d5ebef5db5ada72d421e9333</originalsourceid><addsrcrecordid>eNpdkcFu3CAURVGVqpmk_YBuKtRFd07BGGO6q0ZpEilSN-0aPcNzh8g2LuCM8gv96jCZkSplc3mLc-8DLiEfObvijKmvqWirqiIVk7Ws2jdkwxvRVFo3-oxsmFKsElx35-QipQfGWN1p_o6ccyUayRjfkH_XIfk5LDs_eksHSNb77NM3GnEJMdMw0LwP1ELCRGF2FGh6ShknyIWP-Ohx_wLtkI4-Y4S8RqQOYfTzH7r3eUdtGb2FkT5C9NCPJSnvINMlovO27FizDRO-J28HGBN-OJ2X5PeP61_b2-r-583d9vt9ZYWsc1WXN9hedMiZckzrbrBMQKMl711tlWV6AN2gVE5ij4N0vQQHqnZNzVELIS7Jl2PuEsPfFVM2k08WxxFmDGsy6vBtou0K-PkV-BDWOJe7ma7jtWpFywvEj5CNIaWIg1minyA-Gc7MoSVzbMkUMYeWTFs8n07Baz-h--841SKeAU29j9c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881276361</pqid></control><display><type>article</type><title>Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Endo, Yukie ; Tamura, Atsushi ; Matsushima, Youichiro ; Iwasaki, Tomoko ; Hasegawa, Michiko ; Nagai, Yayoi ; Ishikawa, Osamu</creator><creatorcontrib>Endo, Yukie ; Tamura, Atsushi ; Matsushima, Youichiro ; Iwasaki, Tomoko ; Hasegawa, Michiko ; Nagai, Yayoi ; Ishikawa, Osamu</creatorcontrib><description>We reported two patients with refractory eosinophilic fasciitis (EF) and provided a systematic review of the literature to determine the clinical variables associated with prognosis of EF. We enrolled 88 cases, whose clinical characteristics were analyzed by separating the patients into two or three groups based on outcome. The incidence of certain clinical and pathological features differed among the groups. In particular, the incidence of morphea-like skin lesions in patients with refractory fibrosis was significantly higher than in patients without refractory fibrosis (p = 0.003). Patients with morphea-like skin lesions were 1.9 times more likely to develop persistent fibrosis than patients without these lesions (95% confidence intervals, 1.5-2.5). A younger age (under 12 years) at onset was associated with a 1.6 times greater risk of residual fibrosis (95% confidence interval, 1.1-2.2). Trunk involvement was associated with a 1.4 times greater risk of residual fibrosis (95% confidence interval, 1.0-2.0). Histopathologically, the presence of dermal fibrosclerosis was associated with a 1.4 times greater risk of refractory fibrosis (95% confidence interval, 1.0-2.1). We consider these clinical characteristics, notably the presence of morphea-like skin lesions may be an important risk factor for developing residual fibrosis in EF patients.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-006-0525-6</identifier><identifier>PMID: 17345001</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Adult ; Aged ; Anti-Inflammatory Agents - therapeutic use ; Eosinophilia - complications ; Eosinophilia - drug therapy ; Eosinophilia - immunology ; Fasciitis ; Fasciitis - blood ; Fasciitis - complications ; Fasciitis - drug therapy ; Female ; Fibrosis ; Fibrosis - etiology ; Humans ; Leukocytes (eosinophilic) ; Literature reviews ; Medical diagnosis ; Patients ; Prognosis ; Remission Induction ; Risk factors ; Scleroderma ; Scleroderma, Localized - blood ; Scleroderma, Localized - complications ; Scleroderma, Localized - immunology ; Skin diseases ; Skin lesions ; Steroids - therapeutic use</subject><ispartof>Clinical rheumatology, 2007-09, Vol.26 (9), p.1445-1451</ispartof><rights>Clinical Rheumatology 2007.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-2289cb38e107d0998fc03a4951bd2c7c09fa94e57d5ebef5db5ada72d421e9333</citedby><cites>FETCH-LOGICAL-c352t-2289cb38e107d0998fc03a4951bd2c7c09fa94e57d5ebef5db5ada72d421e9333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17345001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Endo, Yukie</creatorcontrib><creatorcontrib>Tamura, Atsushi</creatorcontrib><creatorcontrib>Matsushima, Youichiro</creatorcontrib><creatorcontrib>Iwasaki, Tomoko</creatorcontrib><creatorcontrib>Hasegawa, Michiko</creatorcontrib><creatorcontrib>Nagai, Yayoi</creatorcontrib><creatorcontrib>Ishikawa, Osamu</creatorcontrib><title>Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><description>We reported two patients with refractory eosinophilic fasciitis (EF) and provided a systematic review of the literature to determine the clinical variables associated with prognosis of EF. We enrolled 88 cases, whose clinical characteristics were analyzed by separating the patients into two or three groups based on outcome. The incidence of certain clinical and pathological features differed among the groups. In particular, the incidence of morphea-like skin lesions in patients with refractory fibrosis was significantly higher than in patients without refractory fibrosis (p = 0.003). Patients with morphea-like skin lesions were 1.9 times more likely to develop persistent fibrosis than patients without these lesions (95% confidence intervals, 1.5-2.5). A younger age (under 12 years) at onset was associated with a 1.6 times greater risk of residual fibrosis (95% confidence interval, 1.1-2.2). Trunk involvement was associated with a 1.4 times greater risk of residual fibrosis (95% confidence interval, 1.0-2.0). Histopathologically, the presence of dermal fibrosclerosis was associated with a 1.4 times greater risk of refractory fibrosis (95% confidence interval, 1.0-2.1). We consider these clinical characteristics, notably the presence of morphea-like skin lesions may be an important risk factor for developing residual fibrosis in EF patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Eosinophilia - complications</subject><subject>Eosinophilia - drug therapy</subject><subject>Eosinophilia - immunology</subject><subject>Fasciitis</subject><subject>Fasciitis - blood</subject><subject>Fasciitis - complications</subject><subject>Fasciitis - drug therapy</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Fibrosis - etiology</subject><subject>Humans</subject><subject>Leukocytes (eosinophilic)</subject><subject>Literature reviews</subject><subject>Medical diagnosis</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Remission Induction</subject><subject>Risk factors</subject><subject>Scleroderma</subject><subject>Scleroderma, Localized - blood</subject><subject>Scleroderma, Localized - complications</subject><subject>Scleroderma, Localized - immunology</subject><subject>Skin diseases</subject><subject>Skin lesions</subject><subject>Steroids - therapeutic use</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkcFu3CAURVGVqpmk_YBuKtRFd07BGGO6q0ZpEilSN-0aPcNzh8g2LuCM8gv96jCZkSplc3mLc-8DLiEfObvijKmvqWirqiIVk7Ws2jdkwxvRVFo3-oxsmFKsElx35-QipQfGWN1p_o6ccyUayRjfkH_XIfk5LDs_eksHSNb77NM3GnEJMdMw0LwP1ELCRGF2FGh6ShknyIWP-Ohx_wLtkI4-Y4S8RqQOYfTzH7r3eUdtGb2FkT5C9NCPJSnvINMlovO27FizDRO-J28HGBN-OJ2X5PeP61_b2-r-583d9vt9ZYWsc1WXN9hedMiZckzrbrBMQKMl711tlWV6AN2gVE5ij4N0vQQHqnZNzVELIS7Jl2PuEsPfFVM2k08WxxFmDGsy6vBtou0K-PkV-BDWOJe7ma7jtWpFywvEj5CNIaWIg1minyA-Gc7MoSVzbMkUMYeWTFs8n07Baz-h--841SKeAU29j9c</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>Endo, Yukie</creator><creator>Tamura, Atsushi</creator><creator>Matsushima, Youichiro</creator><creator>Iwasaki, Tomoko</creator><creator>Hasegawa, Michiko</creator><creator>Nagai, Yayoi</creator><creator>Ishikawa, Osamu</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome</title><author>Endo, Yukie ; Tamura, Atsushi ; Matsushima, Youichiro ; Iwasaki, Tomoko ; Hasegawa, Michiko ; Nagai, Yayoi ; Ishikawa, Osamu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-2289cb38e107d0998fc03a4951bd2c7c09fa94e57d5ebef5db5ada72d421e9333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Eosinophilia - complications</topic><topic>Eosinophilia - drug therapy</topic><topic>Eosinophilia - immunology</topic><topic>Fasciitis</topic><topic>Fasciitis - blood</topic><topic>Fasciitis - complications</topic><topic>Fasciitis - drug therapy</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Fibrosis - etiology</topic><topic>Humans</topic><topic>Leukocytes (eosinophilic)</topic><topic>Literature reviews</topic><topic>Medical diagnosis</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Remission Induction</topic><topic>Risk factors</topic><topic>Scleroderma</topic><topic>Scleroderma, Localized - blood</topic><topic>Scleroderma, Localized - complications</topic><topic>Scleroderma, Localized - immunology</topic><topic>Skin diseases</topic><topic>Skin lesions</topic><topic>Steroids - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Endo, Yukie</creatorcontrib><creatorcontrib>Tamura, Atsushi</creatorcontrib><creatorcontrib>Matsushima, Youichiro</creatorcontrib><creatorcontrib>Iwasaki, Tomoko</creatorcontrib><creatorcontrib>Hasegawa, Michiko</creatorcontrib><creatorcontrib>Nagai, Yayoi</creatorcontrib><creatorcontrib>Ishikawa, Osamu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Endo, Yukie</au><au>Tamura, Atsushi</au><au>Matsushima, Youichiro</au><au>Iwasaki, Tomoko</au><au>Hasegawa, Michiko</au><au>Nagai, Yayoi</au><au>Ishikawa, Osamu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome</atitle><jtitle>Clinical rheumatology</jtitle><addtitle>Clin Rheumatol</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>26</volume><issue>9</issue><spage>1445</spage><epage>1451</epage><pages>1445-1451</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>We reported two patients with refractory eosinophilic fasciitis (EF) and provided a systematic review of the literature to determine the clinical variables associated with prognosis of EF. We enrolled 88 cases, whose clinical characteristics were analyzed by separating the patients into two or three groups based on outcome. The incidence of certain clinical and pathological features differed among the groups. In particular, the incidence of morphea-like skin lesions in patients with refractory fibrosis was significantly higher than in patients without refractory fibrosis (p = 0.003). Patients with morphea-like skin lesions were 1.9 times more likely to develop persistent fibrosis than patients without these lesions (95% confidence intervals, 1.5-2.5). A younger age (under 12 years) at onset was associated with a 1.6 times greater risk of residual fibrosis (95% confidence interval, 1.1-2.2). Trunk involvement was associated with a 1.4 times greater risk of residual fibrosis (95% confidence interval, 1.0-2.0). Histopathologically, the presence of dermal fibrosclerosis was associated with a 1.4 times greater risk of refractory fibrosis (95% confidence interval, 1.0-2.1). We consider these clinical characteristics, notably the presence of morphea-like skin lesions may be an important risk factor for developing residual fibrosis in EF patients.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>17345001</pmid><doi>10.1007/s10067-006-0525-6</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0770-3198 |
| ispartof | Clinical rheumatology, 2007-09, Vol.26 (9), p.1445-1451 |
| issn | 0770-3198 1434-9949 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70770368 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Adult Aged Anti-Inflammatory Agents - therapeutic use Eosinophilia - complications Eosinophilia - drug therapy Eosinophilia - immunology Fasciitis Fasciitis - blood Fasciitis - complications Fasciitis - drug therapy Female Fibrosis Fibrosis - etiology Humans Leukocytes (eosinophilic) Literature reviews Medical diagnosis Patients Prognosis Remission Induction Risk factors Scleroderma Scleroderma, Localized - blood Scleroderma, Localized - complications Scleroderma, Localized - immunology Skin diseases Skin lesions Steroids - therapeutic use |
| title | Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T07%3A51%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eosinophilic%20fasciitis:%20report%20of%20two%20cases%20and%20a%20systematic%20review%20of%20the%20literature%20dealing%20with%20clinical%20variables%20that%20predict%20outcome&rft.jtitle=Clinical%20rheumatology&rft.au=Endo,%20Yukie&rft.date=2007-09-01&rft.volume=26&rft.issue=9&rft.spage=1445&rft.epage=1451&rft.pages=1445-1451&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-006-0525-6&rft_dat=%3Cproquest_cross%3E70770368%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881276361&rft_id=info:pmid/17345001&rfr_iscdi=true |